Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994

Archives of Disease in Childhood

Volumn 81, Issue 3, 1999, Pages 202-208

  Stiller, C A ^a   Eatock, E M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Clinical trials; Leukaemia; Referral patterns; Survival

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; DEATH CERTIFICATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL; UNITED KINGDOM;

EID: 0032765521     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.81.3.202     Document Type: Article

References (21)

1. Stiller CA, Draper GJ. The epidemiology of cancer in children. In: Voute PA, Kalifa C, Barretl A, eds. Cancer in children: clinical management, 4th ed. Oxford: Oxford University Press, 1998:1-20.
2. Stiller CA, Draper GJ. Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia. Arch Dis Child 1989;64:657-61.
3. Moti MG, Mann JR, Stiller CA. The United Kingdom children's cancer study group - the first 20 years of growth and development. Eur J Cancer 1997;33:1448-52.
4. Meadows AT, Kramer S, Hopson R, Lustbader E, Jarrett P, Evans AE. Survival in childhood acute lymphocytic leukemia: effect of protocol and place of treatment. Cancer Invest. 1983;1:49-55.
5. Eden OB, Lilleyman JS, Richards S, Shaw MP, Peto J. Results of Medical Research Council childhood leukaemia trial UKALL VIII (report to the Medical Research Council on behalf of the working party on leukaemia in childhood). Br J Haematol 1991;78:187-96.
6. Chessells JM, Bailey C, Richards SM. Intensification of treatment and survival in all children with lymphoblastic leukaemia; results of UK Medical Research Council trial UKALL X. Lancet 1995;345:143-8.
7. Richards S, Burrett J, Hann I, Chessells J, Hill F, Bailey C. Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Leukemia 1998;12:1031-6.
8. Stiller CA, Allen MB, Eatock EM. Childhood cancer in Britain: The National Registry of Childhood Tumours and incidence rates 1978-87. Eur J Cancer 1995;31A:2028-34.
9. Mott MG, Chessells JM, Willoughby MLN, et al. Adjuvant low dose radiation in childhood T cell leukaemia/ lymphoma. Report from the United Kingdom children's cancer study group - UKCCSG. Br J Cancer 1984;50:457-62.
10. Hann IM, Eden OB, Barnes J, Pinkerton CR. "MACHO" chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. Br J Haematol 1990;76:359-64.
11. Atra A, Gerrard M, Hobson R, Imeson JD, Ashley S, Pinkerton CR. Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL) - results of the UK-CCSG 9003 protocol. Br J Cancer 1998;77:2281-5.
12. Chessells JM. Risk analysis in acute lymphoblastic leukaemia: problems and pitfalls, Eur J Cancer 1995;31A: 1656-9.
13. Chessells JM, Eden OB, Bailey CC, Lilleyman JS, Richards SM. Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council working party on childhood leukaemia. Leukemia 1994;8:1275-9.
14. Chessells JM, Richards SM, Bailey CC, Lilleyman JS, Eden OB. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials. Br J Haematol 1995;89:364-72.
15. Wheeler K, Chessells JM, Bailey CC, Richards SM. Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X. Arch Dis Child 1996;74:101-7.
16. Chessells JM, Harrison G, Lilleyman JS, Bailey CC, Richards SM, Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Br J Haematol 1997;98:945-51.
17. Hann IM, Richards SM, Eden OB, Hill FGH. Analyses of the immunophenotype of children treated in the Medical Research Council United Kingdom acute lymphoblastic leukaemia trial XI (MRC UKALL XI). Leukemia 1998;12: 1249-55.
18. Pieters R, den Boer ML, Durian M, et al. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukaemia implications for treatment of infants. Leukemia 1998;12:1344-8.
19. Levitt GA, Stiller CA, Chessells JM. Prognosis of Down's syndrome with acute leukaemia. Arch Dis Child 1990;65: 212-16.
20. Lie SO, Jonmundsson G, Mollander L, Simes MA, Yissing M, Gustafsson G. A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants and children with Down's syndrome. Br J Haematol 1996;94:82-8.
21. Schillinger JA, Grosclaude PC, Honjo S, Quinn MJ, Sloggett A, Coleman MP. Survival after acute lymphocytic leukaemia: effects of socioeconomic status and geographic region. Arch Dis Child 1999;80:111-17.